FdaApplication

ANDA 040424

Back to search

Identifiers

Properties

PropertyValue
applicant_nameMYLAN PHARMACEUTICALS INC
application_typeANDA
approval_date2001-08-20

Products (3)

ProductActive ingredientStrengthDosage form
SPIRONOLACTONESPIRONOLACTONE50MGTABLET;ORAL
SPIRONOLACTONESPIRONOLACTONE25MGTABLET;ORAL
SPIRONOLACTONESPIRONOLACTONE100MGTABLET;ORAL

3 products